ENHANCEMENT OF DISSOLUTION RATE AND FORMULATION DEVELOPMENT OF EFAVIRENZ TABLETS EMPLOYING STARCH PHOSPHATE A NEW MODIFIED STARCH
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2011, Vol 3, Issue 2
Abstract
The objective of the study is to prepare, characterize and evaluate starch phosphate, a new modified starch as a carrier in solid dispersions for enhancing the dissolution rate of Efavirenz. The feasibility of formulating solid dispersions of Efavirenz in starch phosphate into compressed tablets with enhanced dissolution rate was also investigated. Starch phosphate was prepared by reacting starch with di-sodium hydrogen orthophosphate anhydrous at elevated temperatures. It was insoluble in water and has good swelling (400%) property without pasting or gelling when heated in water. Solid dispersions of Efavirenz in starch phosphate were prepared by solvent evaporation method employing various weight ratios of drug: starch phosphate such as 2:1(SD-1), 1:1(SD-2), 1:2(SD-3), 1:3(SD-4) and 1:9(SD-5) and were evaluated for dissolution rate and efficiency. All the solid dispersions prepared gave rapid and higher dissolution of Efavirenz when compared to pure drug. Dissolution followed first order kinetics. A 13.98 and 31.37 fold increase in the dissolution rate (K1) of Efavirenz was observed with solid dispersions SD-4 and SD-5 respectively. The DE30 was also increased from 10.66% in the case of Efavirenz pure drug to 51.13% and 71.51% in the case of these solid dispersions. Efavirenz (50 mg) tablets were prepared employing Efavirenz alone and its solid dispersions SD-3 and SD-4 by wet granulation method and were evaluated. Efavirenz tablets formulated employing its solid dispersions in starch phosphate gave rapid and higher dissolution rate and DE30 when compared to plain and commercial tablets. A 16.71 and 31.04 fold increase in the dissolution rate (K1) was observed with tablet formulations containing solid dispersions SD-3 and SD-4 respectively when compared to plain tablets.
Authors and Affiliations
K. P. R. Chowdary, Veeraiah Enturi
Keywords
Related Articles
- EP ID EP624962
- DOI -
- Views 71
- Downloads 0
FORMULATION AND IN-VITRO EVALUATION OF POLYHERBAL MICRO-EMULGEL CONTAINING TINOSPORA CORDIFOLIA AND CURCUMIN FOR TREATMENT OF ARTHRITIS
Arthritis is the condition which is associated with inflammation of a joint, pain, swelling, and stiffness. Drug delivery to the target site remains a challenge due to ineffective drug delivery system. An attempt has bee...
GASTRORETENTIVE DRUG DELIVERY SYSTEM OF LEVO-SALBUTAMOL SULPHATE: FORMULATION AND IN VITRO EVALUATION
In order to prepare the sustained release tablet with levo-salbutamol sulphate we have used these excipients methylcellulose, PVPK30, magnesium stearate, talc, isopropyl alcohol, microcrystalline cellulose, lactose, HPMC...
DETERMINATION OF BIOACTIVE COMPONENTS OF ANNONA SQUAMOSA L LEAF BY GC- MS ANALYSIS
Annona squamosa Linn, commonly known as Sugar apple, belonging to the family Annonaceae, is said to show varied medicinal effects, including insecticide, antiovulatory and abortifacient. Hence the present investigation w...
FORMULATION AND EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF GLIBENCLAMIDE
Matrix type transdermal patches containing Glibenclamide were prepared using three different polymers by solvent evaporation technique. Aluminium foil cup method was used as a substrate. Polyethylene glycol (PEG) 400 was...
METERED DOSE INHALATION FORMULATIONS OF SALBUTAMOL SULPHATE USING NON-CFC PROPELLANT TETRAFLUOROETHANE
Salbutamol sulphate metered dose inhaler formulations were developed with chlorine free, non-CFC propellant Tetrafluoroethane. Suspension formulations were prepared with 4 mg of oleic acid as the surfactant and varying p...